Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Mizrahi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|April 18, 2020
Immunotherapy in Gastrointestinal MalignanciesJonathan Mizrahi, Shubham Pant
Cureus|October 4, 2023
Pulmonary Tumor Thrombotic Microangiopathy Caused by Esophageal Adenocarcinoma: A Case ReportJames O Peeples, Joshua King, Victoria Chung, et al.
The Oncologist|April 22, 2021
Pancreas Cancer-Associated Pain ManagementAndrew L Coveler, Jonathan Mizrahi, Bory Eastman, et al.
Nature Communications|February 16, 2017
Demonstration of qubit operations below a rigorous fault tolerance threshold with gate set tomographyRobin Blume-Kohout, John King Gamble, Erik Nielsen, et al.
Nature Communications|June 26, 2018
Publisher Correction: Demonstration of qubit operations below a rigorous fault tolerance threshold with gate set tomographyRobin Blume-Kohout, John King Gamble, Erik Nielsen, et al.
Cancers|September 13, 2025
Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and OutcomesKelley G Núñez, Tyler Sandow, Alexandre Grahovac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal CancerMichael Cecchini, Sae-Won Han, Soohyeon Lee, et al.
Cancer Cell|January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC programSalvador Alonso, Kanwal Raghav, Van K Morris, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 18, 2020
Immunotherapy in Gastrointestinal MalignanciesJonathan Mizrahi, Shubham Pant
Cureus|October 4, 2023
Pulmonary Tumor Thrombotic Microangiopathy Caused by Esophageal Adenocarcinoma: A Case ReportJames O Peeples, Joshua King, Victoria Chung, et al.
The Oncologist|April 22, 2021
Pancreas Cancer-Associated Pain ManagementAndrew L Coveler, Jonathan Mizrahi, Bory Eastman, et al.
Nature Communications|February 16, 2017
Demonstration of qubit operations below a rigorous fault tolerance threshold with gate set tomographyRobin Blume-Kohout, John King Gamble, Erik Nielsen, et al.
Nature Communications|June 26, 2018
Publisher Correction: Demonstration of qubit operations below a rigorous fault tolerance threshold with gate set tomographyRobin Blume-Kohout, John King Gamble, Erik Nielsen, et al.
Cancers|September 13, 2025
Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and OutcomesKelley G Núñez, Tyler Sandow, Alexandre Grahovac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal CancerMichael Cecchini, Sae-Won Han, Soohyeon Lee, et al.
Cancer Cell|January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC programSalvador Alonso, Kanwal Raghav, Van K Morris, et al.
Pageof 1